Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Newly-Published Study Reinforces Efficacy Of HOTSHOT® In Preventing And Treating Muscle Cramps

Randomized, Controlled, Blinded Human Efficacy Study of Athletes Conducted by Penn State University


News provided by

HOTSHOT

Mar 23, 2017, 07:45 ET

Share this article

Share toX

Share this article

Share toX

BOSTON, March 23, 2017 /PRNewswire/ -- Despite the prevalence of muscle cramps, these debilitating and sometimes competition-ending occurrences are poorly understood and can be crippling for athletes at any level. Millions of athletes and fitness enthusiasts suffer from painful, unpredictable and game-stopping muscle cramps that affect strength and physical abilities despite proper training, nutrition and hydration. Common, unproven theories on the cause of muscle cramps include dehydration and electrolyte imbalance, but a newly-published study in the journal of Muscle & Nerve features breakthrough research that muscle cramps originate from hyper-excited motor neurons and can be addressed by using HOTSHOT®, a spicy 1.7-ounce sports shot.

(L-R): Roderick MacKinnon, M.D., HOTSHOT Co-inventor, Professor, Rockefeller and HHMI; Nobel Prize 2003, and Larry Kenney, Ph.D., Professor of Physiology, Kinesiology and Marie Underhill Noll chair in Human Performance at Penn State University
(L-R): Roderick MacKinnon, M.D., HOTSHOT Co-inventor, Professor, Rockefeller and HHMI; Nobel Prize 2003, and Larry Kenney, Ph.D., Professor of Physiology, Kinesiology and Marie Underhill Noll chair in Human Performance at Penn State University

Muscle & Nerve is a reputable, international and interdisciplinary publication focusing on the latest scientific studies concerning the muscle, neuromuscular junction and the central nervous system.  The study, conducted by researchers at the esteemed Noll Laboratory at Penn State University, shows that targeting transient receptor potential (TRP) channels through activators contained in HOTSHOT stops muscle cramps where they start: at the nerve. The published findings from Penn State indicate that taking HOTSHOT decreased the duration and intensity of cramps in this carefully controlled experiment. In addition, when cramps did occur, study participants reported decreased muscle soreness immediately after the cramp ended.

"The study that we undertook at Penn State was a randomized, placebo-controlled, double-blind study, and I think that athletes appreciate the solid science that demonstrates HOTSHOT's ability to control muscle cramps. HOTSHOT was significantly more effective at mitigating muscle cramps than a control beverage without the active ingredients," said W. Larry Kenney, Ph.D., FASCM, Marie Underhill Noll Chair in Human Performance and Professor of Physiology and Kinesiology at Penn State University. "While HOTSHOT was effective at mitigating the magnitude of muscle cramps, it did not affect any of the fine motor skills inherent in many sports. The findings suggest that HOTSHOT can level the playing field for many athletes who regularly experience muscle cramps."

Muscle cramps can be the difference between victory over an opponent or achieving a personal best in an event or competition. What sets HOTSHOT apart from other products is the depth of the science supporting it.

"Our scientific insight led to the discovery that sensory neurons affecting muscle function can be stimulated via TRP ion channels in order to prevent and treat muscle cramps," said Nobel Prize-winning neuroscientist/endurance athlete Rod MacKinnon, MD & co-inventor of HOTSHOT. "We have scientifically proven the efficacy of HOTSHOT on muscle cramps and are exploring HOTSHOT's additional potential benefits on Neuro Muscular Performance in collaboration with other academic institutions."

Invented by MacKinnon, in collaboration with Harvard Medical School neurobiology professor, Bruce Bean, HOTSHOT is comprised of a proprietary formula of GMO-free organic ingredients with a spicy kick. HOTSHOT is also NSF Certified for Sport® as well as vegan and gluten-free.  Consumed before, during or after exercise, HOTSHOT facilitates the synchronization of communication between the nerves and muscles thereby boosting an athlete's Neuro Muscular Performance (NMP) to prevent and treat muscle cramps.

Many existing "remedies" that target the muscle have limited scientific evidence that they work. HOTSHOT is a brand new concept in sports nutrition.  It works by stimulating sensory nerves to affect muscle function.  No other consumer product has demonstrated significant efficacy in mitigating muscle cramps. The proprietary HOTSHOT formulation has been extensively tested in clinical settings, as well as by amateur and world-class athletes across endurance sports, track and field, professional football and tennis.

HOTSHOT is available online at www.TeamHOTSHOT.com, on Amazon.com and at select specialty retailers in California, Colorado, Illinois, Massachusetts and Texas.  A single serve bottle is $7 USD, while 6-bottle and 12-bottle packs are $35 and $65 USD, respectively. 

To learn more about HOTSHOT and the science around Neuro Muscular Performance, visit www.TeamHOTSHOT.com. Join the conversation on Facebook, Twitter and Instagram.

About HOTSHOT

Invented by Rod MacKinnon, a Nobel Prize-winning neuroscientist and endurance athlete, in collaboration with a Harvard Medical School neurobiology professor Bruce Bean, HOTSHOT® is the sports shot with a kick that is scientifically proven to prevent and treat muscle cramps. A scientific breakthrough in sports nutrition, HOTSHOT is a kick-ass proprietary formulation of organic ingredients that boosts Neuro Muscular Performance – how an athlete's nerves and muscles work together in an optimal way. MacKinnon and Bean spent several years calibrating this precise formulation of Transient Receptor Potential (TRP) activator ingredients that stimulate TRP ion channels in the mouth, esophagus and stomach that directly influence and regulate nerve function. Translation? HOTSHOT stops muscle cramps where they start – at the nerve – allowing athletes to push harder, train longer and finish stronger. HOTSHOT is a USDA Certified Organic product that is non-GMO Project Verified and NSF Certified for Sport®, as well as vegan and gluten-free. To learn more, visit www.TeamHOTSHOT.com. HOTSHOT is a product of Flex Innovation Group LLC, a division of Flex Pharma, Inc. (Nasdaq FLKS).

SOURCE HOTSHOT

Related Links

http://www.TeamHOTSHOT.com

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.